The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.90
Bid: 7.80
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.20 (2.564%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.90
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update: Mosa Meat

7 Dec 2020 13:00

RNS Number : 7893H
Agronomics Limited
07 December 2020
 

7 December 2020

 

Agronomics Limited

 

("Agronomics" or the "Company")

 

Portfolio Update: Mosa Meat's Series B Funding Reaches US$ 75 million

 

Agronomics is pleased to announce that portfolio company Mosa Meat B.V. ("Mosa Meat"), a cultivated meat company based in the Netherlands, has completed its Series B fundraise of US$ 75 million. Agronomics participated in Mosa Meat's first close of its Series B financing round, with a US $4.1 million commitment, split into two tranches, as outlined in the announcement on 25th September 2020. Agronomics expects to have a minimum equity interest on a fully diluted basis of 1.62 per cent. Mosa Meat is focussed on cultivated beef products initially, and intends to have products approved in the EU in 2023.

 

The announcement is set out below with no material changes or adjustments:

 

Mosa Meat backed by leading global impact investors, bringing oversubscribed round to $75M

MAASTRICHT, The Netherlands (Dec 7, 2020) -- Mosa Meat, the European food technology company that introduced the world's first cultivated beef hamburger in 2013, announced the second closing of its Series B funding. This second closing of $20M brings the total raised so far in the round to $75M.

 

The funding brings together leading global investors who are dedicated to sustainability, and to supporting Mosa Meat in its mission to develop a cleaner, kinder way of making real beef. These include Blue Horizon Ventures, Target Global, ArcTern Ventures and Rubio Impact Ventures. Mitsubishi Corporation, Japan, the global integrated business enterprise that develops and operates businesses together with its offices and subsidiaries in approximately 90 countries and regions worldwide, as well as a global network of around 1,700 group companies, also invested in the round.

 

"We are delighted to welcome our new partners," said Maarten Bosch, CEO of Mosa Meat. "As well as bringing immense strategic capabilities and expertise, they share our strong commitment to increasing the sustainability of our global food system".

 

Mosa Meat will use the funds to extend its current pilot production facility at its home in Maastricht, develop an industrial-sized production line, expand its team, and introduce delicious cultivated beef to consumers.

 

The Series B funding round is led by Luxembourg-based Blue Horizon Ventures, the food technology fund that aims to support and promote a positive global impact on the environment, human health, and animal welfare .

 

Mosa Meat welcomes this strong group of mission-aligned investors only two years after its successful Series A funding, which was led by M Ventures and Bell Food Group.

 

PRESS CONTACT

For more information and interview requests, please contact:

[English] Sarah Lucas: +44 7828 362 223, sarah@mosameat.com

[Dutch] Tim van de Rijdt: +316 1241 2434, tim@mosameat.com

 

About Mosa Meat

Mosa Meat is a Netherlands-based food technology company, pioneering a cleaner, kinder way to make real beef. Mosa Meat's founders Mark Post and Peter Verstrate introduced the world's first cultivated beef hamburger in 2013, by growing it directly from cow cells. Mosa Meat is now scaling up production to make the same beef that people love, but that is kinder to animals, better for the environment, and safer to eat.

 

About Agronomics

Agronomics is a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 14 companies at the Seed to Series B stage in this rapidly advancing sector. It seeks to secure a 5-10% initial ownership in technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/

 

About the Cultivated Meat Sector

Funding in the cultivated (cell-based) meat sector is growing rapidly with US$ 170 million invested globally between 2016 - 2019 and over US$ 270 million already raised in 2020 alone. Additional financings are anticipated as the capital requirements of these companies grows to build out and scale up manufacturing facilities. Currently, it is estimated that there are 60 companies globally within the sector. AT Kearney, a global consultancy, has predicted that Cultivated Meat's market share of meat consumption will be 35% by 2040.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

 

For further information please contact:

 

Agronomics

Limited

Beaumont

Cornish Limited

Cenkos

Securities Plc

Peterhouse Capital

Limited

TB Cardew

The Company

Nomad

Joint Broker

Joint Broker

PR Relations

Richard Reed

Denham Eke

Roland Cornish

James Biddle

Giles Balleny

Nick Searle

Lucy Williams

Charles Goodfellow

Ed Orlebar

Joe McGregor

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFULDLFBBLLBFBD
Date   Source Headline
6th Oct 20227:00 amRNSPortfolio Company VitroLabs Update
26th Sep 20228:48 amRNSEdison issues flash on Agronomics (ANIC)
21st Sep 20227:00 amRNSPortfolio Company Update: Onego Bio
21st Sep 20227:00 amRNSAgronomics Capital Markets Day 3rd November
8th Sep 20227:00 amRNSPortfolio Update: Bond Pet Foods Completes Funding
7th Sep 20227:00 amRNSPortfolio Company Onego Bio Awarded Grant Funding
11th Aug 20227:00 amRNSEdison issues update on Agronomics (ANIC)
4th Aug 20227:00 amRNSAgronomics Leads All G Foods Series A Financing
1st Aug 20227:00 amRNSAgronomics Leads Clean Food Group’s Seed Financing
25th Jul 20224:40 pmRNSSecond Price Monitoring Extn
25th Jul 20224:35 pmRNSPrice Monitoring Extension
22nd Jul 20227:00 amRNSNet Asset Value calculation to 30 June 2022
20th Jul 20229:03 amRNSPortfolio Company Update: Meatable
18th Jul 202212:24 pmRNSAgronomics July 2022 Newsletter
14th Jul 20227:00 amRNSAppointment of Joint Corporate Broker
8th Jul 202212:29 pmRNSInvestee Company Update: Tropic Biosciences
5th Jul 20227:00 amRNSExercise of Warrants and Total Voting Rights
20th Jun 20227:00 amRNSFinancing of Liberation Labs with CPT Capital
16th May 20229:52 amRNSHolding(s) in Company
6th May 20227:00 amRNSAgronomics Follow-on Investment in CellX
4th May 20229:00 amRNSPortfolio Company VitroLabs completes financing
25th Apr 20227:00 amRNSIssue of Performance Shares & Directors' Dealings
22nd Apr 20227:00 amRNSNet Asset Value calculation to 31st March 2022
5th Apr 20221:25 pmRNSExercise of Warrants, Total Voting Rights
23rd Mar 20229:30 amRNSAnnounces the Trading Facility of Warrants
21st Mar 20228:00 amRNSLaunch of Cultivated Meat Pet Food Venture
18th Mar 20227:00 amRNSANIC Joins the Alternative Proteins Association
14th Mar 20227:00 amRNSAgronomics Follow on Investment in GALY CO.
8th Mar 20227:00 amRNSAgronomics co-leads SuperMeat’s Series A Financing
24th Feb 20227:00 amRNSAgronomics welcomes Senior Investment Associate
22nd Feb 20227:00 amRNSAgronomics Leads Onego Bio's Seed Funding Round
21st Feb 20228:33 amRNSAgronomics Acquires Stake in Geltor, Inc
3rd Feb 20227:00 amRNSInterim Results
2nd Feb 202212:17 pmRNSResult of AGM
27th Jan 20228:00 amRNSPortfolio Company Update: BlueNalu
10th Jan 20228:12 amRNSExercise of Warrants
24th Dec 202111:51 amRNSHolding(s) in Company
23rd Dec 20211:11 pmRNSHolding(s) in Company
23rd Dec 202110:53 amRNSAgronomics December 2021 Newsletter
21st Dec 20212:29 pmRNSOpen Offer Results Subscription PDMR Dealing & TVR
16th Dec 20217:00 amRNSFinal Results and Notice of AGM
10th Dec 202111:08 amRNSHolding(s) in Company
8th Dec 20218:30 amRNSPortfolio Company Update: The EVERY Company
2nd Dec 20211:30 pmRNSResults of the Placing and Subscription
1st Dec 202111:30 amRNSProposed Fundraise to raise minimum £25 million
19th Nov 20217:00 amRNSAgronomics Leads Ohayo Valley’s Pre-Seed Funding
11th Nov 20217:00 amRNSPortfolio Company Update: Tropic Biosciences
5th Nov 20217:00 amRNSNet Asset Value calculation to 30 September 2021
4th Nov 20217:00 amRNSUS$ 8 million investment in The EVERY Company
3rd Nov 20217:00 amRNSAnnounces Launch of New Website

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.